Back
Hikma Pharmaceuticals Plc Vs. MiNK Therapeutics, Inc. Industry Stock Comparison
Sell
33
HKMPY
Hikma Pharmaceuticals Plc
Last Price:
$40.42
Seasonality Move:
2.89%
Sell
32
INKT
MiNK Therapeutics, Inc.
Last Price:
$11.68
Seasonality Move:
-18.07%
Sell
33
Hikma Pharmaceuticals Plc (HKMPY)
is a Sell
Is Hikma Pharmaceuticals Plc a Buy, Sell or Hold?
-
The current Hikma Pharmaceuticals Plc [HKMPY] share price is $40.42. The Score for HKMPY is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
HKMPY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
MiNK Therapeutics, Inc. (INKT)
is a Sell
Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?
-
The current MiNK Therapeutics, Inc. [INKT] share price is $11.59. The Score for INKT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HKMPY Stock Price Chart
What is Hikma Pharmaceuticals Plc's stock price today?
-
The Hikma Pharmaceuticals Plc share price today is $40.42Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HKMPY is experiencing slight buying pressure.
INKT Stock Price Chart
What is MiNK Therapeutics, Inc.'s stock price today?
-
The MiNK Therapeutics, Inc. share price today is $11.59Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing slight buying pressure.
HKMPY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.84 | Sell |
| Relative Strength Index (14 RSI): | 40.13 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.69 - 42.17) | Sell |
| Bollinger Bands (100): | (42.43 - 49.31) | Sell |
INKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 44.79 | Sell |
| Chaikin Money Flow: | 9780 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.89 - 12.35) | Sell |
| Bollinger Bands (100): | (12.23 - 15.15) | Sell |
HKMPY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.72 | Sell |
| 20-day SMA: | 41.46 | Sell |
| 50-day SMA: | 43.97 | Sell |
| 200-day SMA: | 49.81 | Sell |
| 8-day EMA: | 40.78 | Sell |
| 20-day EMA: | 41.45 | Sell |
| 50-day EMA: | 43.32 | Sell |
| 200-day EMA: | 48.05 | Sell |
INKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.09 | Sell |
| 20-day SMA: | 11.62 | Sell |
| 50-day SMA: | 12.8 | Sell |
| 200-day SMA: | 11.89 | Sell |
| 8-day EMA: | 11.86 | Sell |
| 20-day EMA: | 11.96 | Sell |
| 50-day EMA: | 12.6 | Sell |
| 200-day EMA: | 12.22 | Sell |
Hikma Pharmaceuticals Plc Earnings Growth & HKMPY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.
Hikma Pharmaceuticals Plc Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MiNK Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||